Published in Ann Surg on October 01, 1971
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Cell-mediated immunity and blocking serum activity to tolerated allografts in rats. J Exp Med (1973) 0.94
Clinical and experimental organ transplantation. Transplant Proc (1975) 0.75
THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. Surg Gynecol Obstet (1963) 8.04
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor. Nature (1969) 3.20
Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas. Int J Cancer (1969) 2.80
Immunological enhancement of rat kidney grafts. Lancet (1969) 2.73
Cellular and humoral immunity to different types of human neoplasms. Nature (1968) 2.40
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A (1969) 2.28
Rejection of renal allografts: specific immunologic suppression. Science (1968) 1.73
Immunofluorescent examination of biopsies from long-term renal allografts. N Engl J Med (1970) 1.53
Renal transplants in children. Transplant Proc (1969) 1.32
Mechanisms of kidney allograft rejection. Transplant Proc (1969) 1.14
Immunological enchancement of human kidney graft. Lancet (1970) 1.12
Short communication immune mechanisms in human recipients of renal allografts. Cell Immunol (1970) 1.07
Colony inhibition of fibroblasts from chimeric dogs mediated by the dogs' own lymphocytes and specifically abrogated by their serum. Proc Natl Acad Sci U S A (1970) 1.03
Immunologic enhancement of renal allografts in the rat. I. Dissociation of graft survival and antibody response. Fed Proc (1971) 0.95
Antibodies and human transplant rejection. Ann Surg (1969) 0.92
Components and concepts of antigenic strength. Transplant Rev (1969) 0.88
Apparent glomerulonephritis in a homotransplant. Surgery (1966) 0.88
Demonstration of cellular immunity against human tumors. Surg Forum (1969) 0.78
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA (1991) 4.49
Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med (1967) 4.08
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Changes in blood coagulation. Arch Surg (1966) 3.22
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) (1972) 2.82
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50
Fournier's syndrome: necrotizing subcutaneous infection of the male genitalia. J Urol (1979) 2.46
Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys (1993) 2.42
Cellular and humoral immunity to different types of human neoplasms. Nature (1968) 2.40
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A (1969) 2.28
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Structural-functional correlations in renal disease. II. The correlations. Hum Pathol (1970) 2.18
Glomerular cell culture. Lab Invest (1985) 2.16
Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A (1968) 2.12
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Cloning and sequence of cDNA coding for alpha 1-antitrypsin. Proc Natl Acad Sci U S A (1981) 1.91
Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg (1966) 1.89
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol (2004) 1.88
The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg (1998) 1.86
Progress in homotransplantation of the liver. Adv Surg (1966) 1.83
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int J Cancer (1968) 1.73
The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest (1984) 1.72
Homotransplantation of the liver. Transplantation (1967) 1.71
Human glomerular cells in vitro: isolation and characterization. Transplant Proc (1980) 1.69
Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66
Hyperlipidaemia after successful renal transplantation. Lancet (1974) 1.64
Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res (1980) 1.63
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A (1992) 1.58
Hemophilia: role of organ homografts. Science (1969) 1.56
Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg (1968) 1.56
Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol (1988) 1.55
Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A (1994) 1.54
The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
Symptomatology, pathophysiology and treatment of the transurethral resection of the prostate syndrome. Br J Urol (1973) 1.53
Axillary web syndrome after axillary dissection. Am J Surg (2001) 1.49
Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry (1983) 1.47
A lymphoma cell line expressing elevated levels of tyrosine protein kinase activity. J Biol Chem (1983) 1.45
Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer (2000) 1.45
Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest (1980) 1.42
Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). J Immunol (1987) 1.42
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
Post-thyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg (1986) 1.41
Nephrotoxin exposure in utero reduces glomerular number in sclerosis-prone but not sclerosis-resistant mice. Kidney Int (1999) 1.40
Demonstration of the parathyroids during surgery in dogs, with preliminary report of results in some clinical cases. Surgery (1966) 1.39
Late function of the orthotopic liver homograft. Surg Forum (1965) 1.36
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35
The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34
Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest (2001) 1.32
Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int (1988) 1.32
Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol (2001) 1.30
Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest (1996) 1.23
Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res (1983) 1.22
Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney. Arch Surg (1966) 1.22
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem (2001) 1.21
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20
Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest (1991) 1.20
Extracellular matrix in normal and fibrotic human lungs. Am Rev Respir Dis (1985) 1.19
Human glomerular visceral epithelial cells synthesize a basal lamina collagen in vitro. Proc Natl Acad Sci U S A (1979) 1.19
Studies on cellular immunity to human neuroblastoma cells. Int J Cancer (1970) 1.19
Pancreatogastrostomy: a safe drainage procedure after pancreatoduodenectomy. Surgery (1990) 1.18
Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol (2001) 1.18
Studies of progressive glomerular sclerosis in the rat. Am J Pathol (1986) 1.18
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17
Mesangial cells, effect of monocyte products on proliferation and matrix synthesis. Transplant Proc (1982) 1.15
A lymphoma protein with an in vitro site of tyrosine phosphorylation homologous to that in pp60src. J Biol Chem (1982) 1.15
Age-related changes in alpha 1- and alpha 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR. Am J Physiol (1992) 1.14
Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int (1998) 1.13
Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol (1999) 1.12
Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol (1992) 1.11
Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest (1991) 1.11
Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. Kidney Int (2007) 1.11
Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice. Kidney Int (2006) 1.10
Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int (1987) 1.10
Attempted spleen transplant in classical hemophilia. Transplantation (1969) 1.09
Ultrastructure of human renal obsolescent glomeruli. Lab Invest (1969) 1.09
Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med (1991) 1.09
The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation (1967) 1.09
Chronic renal homograft function: correlation with histology and lymphocyte antigen matching. Am J Med (1967) 1.08
Short communication immune mechanisms in human recipients of renal allografts. Cell Immunol (1970) 1.07
Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology (1988) 1.07